Variability in Ejection Fraction Measured By Echocardiography, Gated Single-Photon Emission Computed Tomography, and Cardiac Magnetic Resonance in Patients With Coronary Artery Disease and Left Ventricular DysfunctionPatricia A. Pellikka, Jae K. Oh, Karol Miszalski‐Jamka et al.|JAMA Network Open|2018Cited by 228
Comparison of an Initial Risk-Based Testing Strategy vs Usual Testing in Stable Symptomatic Patients With Suspected Coronary Artery DiseasePamela S. Douglas, Jane Cao, Michael G. Nanna et al.|JAMA Cardiology|2023Cited by 97
Coordinated Care to Optimize Cardiovascular Preventive Therapies in Type 2 DiabetesNeha J. Pagidipati, Jairo Cruz, Adam J. Nelson et al.|JAMA|2023Cited by 93
Incorporating SGLT2i and GLP-1RA for Cardiovascular and Kidney Disease Risk Reduction: Call for Action to the Cardiology CommunityAdam J. Nelson, Christopher B. Granger, Neha J. Pagidipati et al.|Circulation|2021Cited by 79
Use of Lipid-, Blood Pressure–, and Glucose-Lowering Pharmacotherapy in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular DiseaseAdam J. Nelson, Christopher B. Granger, Emily C. O’Brien et al.|JAMA Network Open|2022Cited by 73